Abstract:Alzheimer's disease (AD) is the most common type of dementia and is a serious social and medical problem threatening human health. The present study investigated the effect and underlying action mechanism of triptolide (Tri) on AD progression. Reverse transcription-quantitative PCR and western blotting analysis were used to determine the changes in RNA expression and levels of NF-κB signaling pathway proteins before and after lipopolysaccharide (LPS) induction. Nucleocytoplasmic separation experiments determined the intracellular localization of long non-coding RNA (lncRNA) nuclear paraspeckle assembly transcript 1 (NEAT1). A dual-luciferase assay was used to analyze the binding between NEAT1 and microRNA (miRNA/miR)-361 or tumor necrosis factor receptor-associated factor 2 (TRAF2) and miR-361-3p and RNA pull-down was used to analyze the binding between NEAT1 and miR-361-3p. Cell Counting Kit-8, flow cytometry and ELISA were used to detect the effects of interaction between Tri and NEAT1/miR-361-3p/TRAF2 on cell viability, apoptosis and inflammatory factor levels, respectively. The results showed that LPS-mediated human microglial clone 3 cell line (HMC3) viability decreased and apoptosis and inflammatory factors (IL-1β, IL-6, IL-18 and TNF-α) increased. Tri inhibited LPS-mediated effects in a dose-dependent manner by downregulating NEAT1 expression. NEAT1 is highly expressed in the cytoplasm and reduces the transcription and translation of downstream TRAF2 by acting as a competitive endogenous RNA that adsorbs miR-361-3p. LPS-mediated HMC3 cell injury, inflammation and activation of NF-κB signaling were partially reversed in presence of Tri. The miR-361-3p mimic promoted the Tri effect and overexpression of (ov)-NEAT1 partially reversed the Tri-miR-361-3p combined effect. The effects of ov-NEAT1 were partially attenuated by small interfering (si)-TRAF2. Overall, Tri inhibited the LPS-induced decrease in viability, increase in apoptosis and inflammation and activation of NF-κB signaling in HMC3 cells. Tri regulation affected the NEAT1/miR-361-3p/TRAF2 axis. These findings suggested a potential therapeutic role for Tri in the clinical management of AD by modulating this molecular axis.

Effects of Triptolide on the Synaptophysin Expression of Hippocampal Neurons in the AD Cellular Model

Effects of triptolide on neuronal apoptosis of hippocampus in AD cellar model

Effects of triptolide on degeneration of dendritic spines induced by Aβ 1–40 injection in rat hippocampus

Effects of triptolide on the expression of interleukin-1β mRNA and protein of hippocampus in model rats with Alzheimer′s disease

Effect of triptolide on expression of IL-1α in the hippocampus of model rats with Alzheimer's disease

Triptolide Preserves Cognitive Function and Reduces Neuropathology in a Mouse Model of Alzheimer's Disease.

Effects of Triptolide on Expression of Drebrin and Cofilin in Hippocampus of Rats with Alzheim-er's Disease

Effect of triptolide on expression of C1q in the hippocampus of Alzheimer's disease rats

Triptolide Attenuated Injury Via Inhibiting Oxidative Stress in Amyloid-Beta25–35-treated Differentiated PC12 Cells

Effects of triptolide on the expressions of C1q and C3 after microinjection of beta-amyloid protein into cerebral cortex in rats

Epigenetic mechanisms underlying the effects of triptolide and tripchlorolide on the expression of neuroligin-1 in the hippocampus of APP/PS1 transgenic mice.

Triptolide Inhibited Cytotoxicity of Differentiated PC12 Cells Induced by Amyloid-Beta₂₅₋₃₅ Via the Autophagy Pathway.

Triptolide Improves Alzheimer's Disease by Regulating the NF‑κB Signaling Pathway Through the Lncrna NEAT1/microRNA 361‑3p/traf2 Axis.

Anti-inflammatory and neuroprotective effects of Triptolide via the NF-κB signaling pathway in a rat MCAO model.

Triptolide Derivatives As Potential Multifunctional Anti-Alzheimer Agents: Synthesis and Structure-Activity Relationship Studies

[Tripotolide Ameliorates Inflammation and Apoptosis Induced by Focal Cerebral Ischemia/reperfusion in Rats].

Triptolide inhibits amyloid-β production and protects neural cells by inhibiting CXCR2 activity.

Multiple-Coated PLGA Nanoparticles Loading Triptolide Attenuate Injury of a Cellular Model of Alzheimer's Disease.

Expression of Synaptophysin and Protective Function of Nimodipine after Amyloid-beta Protein Injected into Meynert Nudeus in Rats

Thioperamide attenuates neuroinflammation and cognitive impairments in Alzheimer's disease via inhibiting gliosis

Anti-Inflammatory Activity of 4-(4-(Heptyloxy)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one via Repression of MAPK/NF-κB Signaling Pathways in β-Amyloid-Induced Alzheimer's Disease Models